DUNEDIN, New Zealand – Pacific Edge (NZX, ASX: PEB) today reports successful execution of strategic initiatives to focus the company on the development of its advanced cancer diagnostic tests for inclusion in clinical guidelines
Pacific Edge Limited reported earnings results for the full year ended March 31, 2024. For the full year, the company reported sales was NZD 23.91 million compared to NZD 19.62 million a year ago..
(Sharecast News) - Asia-Pacific markets saw broad declines on Tuesday, led by significant losses in Hong Kong amid sharp falls in basic materials and industrial stocks.
Pacific Edge's eyes on decision | Otago Daily Times Online News odt.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from odt.co.nz Daily Mail and Mail on Sunday newspapers.